Eton Pharmaceuticals (ETON) Preferred Dividend Payments (2018)

Eton Pharmaceuticals (ETON) reported Preferred Dividend Payments of $22.3 million for Q4 2018, up 2963.37% sequentially from $729000.0 in Q3 2018.

Eton Pharmaceuticals (ETON) Preferred Dividend Payments (2018) Analysis & Trends

Eton Pharmaceuticals (ETON) has 1 years of Preferred Dividend Payments data on file, last reported at $22.3 million in Q4 2018.

  • For the quarter ending Q4 2018, Preferred Dividend Payments changed N/A year-over-year to $22.3 million; the trailing twelve-month figure through Dec 2018 stood at $24.5 million (changed N/A YoY), and the FY2018 full-year result was $24.5 million, up 1551.31% from the prior year.
  • Preferred Dividend Payments advanced to $22.3 million in Q4 2018, from $729000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $22.3 million in Q4 2018 to a low of $706000.0 in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Eton Pharmaceuticals 1.19 Bn 1.16 Bn 13.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 22.33 Mn
Sep 30, 2018 729,000.00
Jun 30, 2018 722,000.00
Mar 31, 2018 706,000.00